Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Cancer and the Circadian Clock.

Shafi AA, Knudsen KE.

Cancer Res. 2019 Aug 1;79(15):3806-3814. doi: 10.1158/0008-5472.CAN-19-0566. Epub 2019 Jul 12. Review.

PMID:
31300477
2.

Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.

Dylgjeri E, McNair C, Goodwin JF, Raymon HK, McCue PA, Shafi AA, Leiby BE, de Leeuw R, Kothari V, McCann JJ, Mandigo AC, Chand SN, Schiewer MJ, Brand LJ, Vasilevskaya I, Gordon N, Laufer TS, Gomella LG, Lallas CD, Trabulsi EJ, Feng FY, Filvaroff EH, Hege K, Rathkopf D, Knudsen KE.

Clin Cancer Res. 2019 Jul 2. doi: 10.1158/1078-0432.CCR-18-2207. [Epub ahead of print]

PMID:
31266833
3.

Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.

Shafi AA, Schiewer MJ, de Leeuw R, Dylgjeri E, McCue PA, Shah N, Gomella LG, Lallas CD, Trabulsi EJ, Centenera MM, Hickey TE, Butler LM, Raj G, Tilley WD, Cukierman E, Knudsen KE.

Eur Urol Oncol. 2018 Sep;1(4):325-337. doi: 10.1016/j.euo.2018.04.019. Epub 2018 Jun 6.

PMID:
30467556
4.

PARP-1 regulates DNA repair factor availability.

Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE.

EMBO Mol Med. 2018 Dec;10(12). pii: e8816. doi: 10.15252/emmm.201708816.

5.

Difficulty accessing data from randomised trials of drugs for heart failure: a call for action.

Fleetcroft R, Ford J, Gollop ND, MacKeith P, Perera K, Shafi AA, Sorefan J, Thurlow C, Wakelin R, Cowie MR, Steel N.

BMJ. 2015 Oct 21;351:h5002. doi: 10.1136/bmj.h5002. Review. No abstract available.

6.

Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.

Shafi AA, Putluri V, Arnold JM, Tsouko E, Maity S, Roberts JM, Coarfa C, Frigo DE, Putluri N, Sreekumar A, Weigel NL.

Oncotarget. 2015 Oct 13;6(31):31997-2012. doi: 10.18632/oncotarget.5585.

7.

Neoadjuvant chemotherapy in locally advanced breast cancer.

Iqbal J, Shafi AA, Alharthi BN.

J Coll Physicians Surg Pak. 2014 Nov;24(11):845-8. doi: 11.2014/JCPSP.845848.

PMID:
25404445
8.
9.

Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.

Krause WC, Shafi AA, Nakka M, Weigel NL.

Int J Biochem Cell Biol. 2014 Sep;54:49-59. doi: 10.1016/j.biocel.2014.06.013. Epub 2014 Jul 4.

10.

Androgen receptors in hormone-dependent and castration-resistant prostate cancer.

Shafi AA, Yen AE, Weigel NL.

Pharmacol Ther. 2013 Dec;140(3):223-38. doi: 10.1016/j.pharmthera.2013.07.003. Epub 2013 Jul 13. Review.

PMID:
23859952
11.

Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression.

Shafi AA, Cox MB, Weigel NL.

Steroids. 2013 Jun;78(6):548-54. doi: 10.1016/j.steroids.2012.12.013. Epub 2013 Feb 1.

12.

Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.

He S, Zhang C, Shafi AA, Sequeira M, Acquaviva J, Friedland JC, Sang J, Smith DL, Weigel NL, Wada Y, Proia DA.

Int J Oncol. 2013 Jan;42(1):35-43. doi: 10.3892/ijo.2012.1698. Epub 2012 Nov 14.

13.

Applying patient centered approach in management of pulmonary tuberculosis: A case report from Malaysia.

Atif M, Sulaiman S, Shafi A, Muttalif A, Ali I, Saleem F.

J Basic Clin Pharm. 2011 Jun;2(3):129-31. Epub 2011 Aug 15.

14.

Fluorescence enhancement of 1-napthol-5-sulfonate by forming inclusion complex with beta-cyclodextrin in aqueous solution.

Abdel-Shafi AA, Al-Shihry SS.

Spectrochim Acta A Mol Biomol Spectrosc. 2009 Apr;72(3):533-7. doi: 10.1016/j.saa.2008.10.052. Epub 2008 Nov 12.

PMID:
19091626
15.

Flow injection fluorimetric determination of chromium(VI) in electroplating baths by luminescence quenching of tris(2,2'-bipyridyl) ruthenium(II).

Hassan SS, Abdel-Shafi AA, Mohammed AH.

Talanta. 2005 Oct 15;67(4):696-702. doi: 10.1016/j.talanta.2005.03.019. Epub 2005 Apr 26.

PMID:
18970227
17.

Photosensitized generation of singlet oxygen from rhenium(I) and iridium(III) complexes.

Abdel-Shafi AA, Bourdelande JL, Ali SS.

Dalton Trans. 2007 Jun 28;(24):2510-6. Epub 2007 May 23.

PMID:
17563786
18.

Spectroscopic studies on the inclusion complex of 2-naphthol-6-sulfonate with beta-cyclodextrin.

Abdel-Shafi AA.

Spectrochim Acta A Mol Biomol Spectrosc. 2007 Mar;66(3):732-8. Epub 2006 Oct 2.

PMID:
17011817
19.

Inclusion complex of 2-naphthylamine-6-sulfonate with beta-cyclodextrin: intramolecular charge transfer versus hydrogen bonding effects.

Abdel-Shafi AA.

Spectrochim Acta A Mol Biomol Spectrosc. 2007 Apr;66(4-5):1228-36. Epub 2006 Jun 23.

PMID:
16949335
21.

Photosensitized generation of singlet oxygen from ruthenium(II) and osmium(II) bipyridyl complexes.

Abdel-Shafi AA, Worrall DR, Ershov AY.

Dalton Trans. 2004 Jan 7;(1):30-6. Epub 2003 Dec 2.

PMID:
15356738
22.

Effect of beta-cyclodextrin on the excited state proton transfer in 1-naphthol-2-sulfonate.

Abdel-Shafi AA.

Spectrochim Acta A Mol Biomol Spectrosc. 2001 Aug;57(9):1819-28.

PMID:
11506032
23.

Shape optimization of metal backing for cemented acetabular cup.

Hedia HS, Abdel-Shafi AA, Fouda N.

Biomed Mater Eng. 2000;10(2):73-82.

PMID:
11086841
24.

The determination of weak acids in aqueous solution by catalytic thermometric titrimetry.

Greenhow EJ, Shafi AA.

Talanta. 1976 Jan;23(1):73-6. No abstract available.

PMID:
18961808

Supplemental Content

Loading ...
Support Center